QDIS Blog

A blog about chemistry, drug development, science, and technology

Pages (999999): [1] 2 3 » ... Last »

January 15, 2008

Nova episode “Conquest of Cold”

by @ 2:53 pm.  Filed under Science

As you may have noticed I’ve had some time to get caught up on programs I tivo’ed. Another program I really enjoyed was Nova’s “Absolute Zero: The Conquest of Cold” which you can watch online for free.

I’ve always been a big fan of Nova and it is on my season pass on my tivo. My only disappointment was how it ended and I won’t ruin it for anyone who hasn’t seen it but thought they could have done more. Then I find out there is going to be another follow on called “Absolute Zero: The Race for Absolute Zero”. I’m hoping my disappointment will be cured with this next episode. It is set to air on Jan 15 at 8 pm at least according to the PBS website.

I highly recommend this Nova episode for anyone with even a passing interest in science. They did an excellent job of covering the history of the study of cold and even though I’ve been a life long scientists, I still learned something, especially about the first use of “air conditioning”.

I am constantly amazed at how little knowledge some of my fellow scientist have of the history of science Many do not seem to be at all interested in the historical aspects of science but I think you can learn a lot about science itself and how it interfaces with society by understanding where we come from. A great example of the history of science not being taught in the area of chemistry (my special area of interest) is the program “Forgotten Genius - Percy Julian“. Although I have taken a course on the history of chemistry and read a couple of books about the history of chemistry and had never heard of Percy Julian. You can also view this program online for free and read a lot of other information on this black chemist and his accomplishments.

I always enjoy these sort of science and history related shows and this reminds me a lot of the Connections series with James Burke that the BBC did several years ago. I really wish TLC of Discover would re-air those episodes. You can still get them on DVD but they are expensive; $149 for 5 DVD ten programs. Connections 2 is also available for the same cost but it doesn’t look like Connections 3 is available.

Technorati Tags:

Email Ed Vawter



Related Posts:
  • Nova ScienceNow Segment on Bird Flu
  • FDA Scrutinizing Kids’ OTC Cold Remedies
  • Searching the Internet Episode 2
  • Phenylephrine reformulation a flop?
  • Your Vote on Nov 7 is Important

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    February 19, 2007

    Recap of last week (week of 02/12/07)

    by @ 2:23 pm.  Filed under Science, Health News, Pharma News, Pharma

    Wow, I go to a conference for a week and all kinds of things happened. Here are some of the headlines that caught my attention.

    FDA

    ‘Accelerated Enforcement’ Now Against Unapproved Drugs: FDA will be accelerating enforcing regulations against unapproved and unregulated drugs and are having weekly meetings to discuss priorities.
    Killing the Goose That Lays the Golden Drugs: An article stating that there is a need to balance drug safety with access to new therapies.
    Press Release: Sanofi-Aventis Announces Update To U.S. Prescribing Information For Ketek - FierceBiotech: More on the Ketek fiasco.
    PharmaLive: FDA Announces Label and Indication Changes for the Antibiotic Ketek
    Sanofi shares slide as FDA delays Acomplia–again - FierceBiotech: More delays for Acomplia in the US; decision to be made by July.
    FDA deny drug application from Advancis - Washington Business Journal: Another antibiotic has hit a snag; Advancis NDA is said to be incomplete and unable to be approved.
    US warns Abraxis BioScience about plant problems | Health | Reuters
    Abraxis Bioscience, Inc., Warning Letter: From the FDA website.

    Government and Congress

    GAO warns of Medicare drug overcharging - Boston.com: The GAO is worried about schemes to overcharge the US government for the Medicare Part D Prescription Benefit. The basis is that the complex set of rules makes it difficult to verify the accuracy of drug prices.
    Biotech trade group warns of price controls - MarketWatch: The leader of BIO warned against the HHS being able to negotiate drug prices and calls them defacto price controls.
    Democrats plan bill for generic biologics - washingtonpost.com: This could be big and I’ve posted before about biogenerics.
    Generic Biotech Drugs Could Save $71B - washingtonpost.com: Another article on biogenerics and what impact it may have.
    Lawmakers unveil bill to create clear pathway for generic biologic drugs
    Newsvine - Texas Gov., Lawmakers in Vaccine Dispute: more about the Gardasil vaccine being required by the govenor for girls in Texas.
    Pfizer’s AIDS drug to get faster review - Yahoo! Finance

    Pharma News

    PharmaLive: Lovenox Patent Infringement Suit Decided Against Sanofi-Aventis
    PharmaLive: New Campaign Champions Changes in Medical Prescribing to End Conflicts of Interest
    Bayer to file for Nexavar approval for liver cancer - Boston.com: I know folks at Onyx and am glad to see this drug proceeding so well.
    Thailand threatens to produce more copycat drugs | Science | Reuters
    Thailand plans to break patents on 14 drugs: firms - Yahoo! News
    British pharmacy pilots over-the-counter Viagra - International Herald Tribune: Brings new meaning to the question, What’s Up? :) PharmaLive: Merck Settles Tax Dispute with Internal Revenue Service
    Eli Lilly Regains Leaked Papers - washingtonpost.com: A judge orders papers related to Zyprexa to be returned to Eli illy.
    PharmaLive: Telik Announces Corporate Restructuring: More lay-offs.
    Ariad says close to cancer drug partnership deal | Health | Reuters
    PharmaLive: Ranbaxy: Press Statement: Federal officals conducted a suprise search of Ranbaxy’s NJ offices.

    Biofuels

    Philadelphia Inquirer | 02/12/2007 | Oil firms speak up on alternative fuels: Major oil companies now want a seat at the table for discussing alternative fuels.
    New theme heard at oil gathering - Los Angeles Times: Another article on big oil and their interest now in biofuels.
    Big Oil says biofuels won’t meet U.S. energy demands - Feb. 15, 2007: more on the big oil views of biofuels.

    Biotech

    United Press International - Health Business - Seattle Genetics’ drugs get orphan status: I know people at Seattle Genetics and think they have a good business model and am glad to see these products get orphan drug status.
    Wired News: Pharm Animals Crank Out Drugs: Another article on pharming, using animals to produce drugs. Covers GTC Biotherapeutics who I’ve mentioned before here and here.
    Biotech posts fastest growth globally: Article on the double digit growth (35%) in India’s biotech industry.
    Hawaii has more biotech bills - Pacific Business News (Honolulu): The Hawai’i state government had 44 bills before it relating to biotech in 2006.

    Other
    Refusing to share samples ‘may cause a vaccine delay’-News-World-Asia-TimesOnline: GSK has attacked the Indonesian government for refusing to supply bird flu samples to other companies for research to develop vaccines.
    Technology Review: Discovering Drugs with Bubbles: I’ll share my views on this in a later post.
    I’ll try to comment on some of these in more detail later this week if I can get some spare time.

    Email Ed Vawter



    Related Posts:
  • Back from Conference and Starting to Post Again
  • Traveling next week
  • Few if any postings this week
  • Drugs moving into the clinic this week
  • Good Article and Timeline for HIV/AIDS

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    January 30, 2007

    Biotech Second Only to Pineapple in Hawai’i

    by @ 11:46 am.  Filed under Science

    I have a certain fondness for Hawai’i and keep track of issues related to science and biotech there. I try to vacation there once a year since it is easily reached from the west coast. I have become friends with several folks there and listen to several podcasts about Hawaii and try to read the online news about the islands.

    Seems that biotech crops are big there and second only to pineapple in terms of dollars generated. The genetically modified seed business is valued at over $70 million. I also know that the industry employes about 2,000 jobs many of which are well paid and they contribute over $7 million in taxes to the local government.

    Biotech now second only to pineapple - Pacific Business News (Honolulu)
    I have mixed feelings about GM crops in Hawaii. I have posted about this before. While I am a supporter of GMO and think it can greatly benefit person-kind, I also know how fragile small isolated environments such as the Hawaiian Islands can be. I also understand and respect those who have concerns and think those need to be adequately addressed.
    Technorati Tags: ,

    Email Ed Vawter



    Related Posts:
  • Hawaii and Biotech Crops (Biopharming)
  • Yahoo! Answers has new RSS features
  • Spending on Biotech Drugs to Reach 25% by 2012
  • NY Times Article on Biotech
  • Chemist to lead study of Titan’s moon

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    January 26, 2007

    New Catalyzed Reaction and Tamiflu

    by @ 3:14 pm.  Filed under Science, Chemistry Articles

    I recently read the C&EN article reviewing chemistry highlights from 2006. It covers a lot of interesting stuff that happened last year but two items caught my attention. One of happenings they cover is Tamaflu which I’ve posted about many times before and the other is about a new organic catalyzed asymmetric reaction. Each by themselves is fairly impressive but I find it interesting that the author did not tie the two together!!

    For those of you not familiar with Tamiflu, here is the structure.

    200701261106

    And then here is the reaction that forms four sterocenters and three carbon-carbon bonds. It is asymmetric and catalyzed by a proline derivative. [Control of four stereocentres in a triple cascade organocatalytic reaction, Dieter Enders, et. al., Nature 441, 861 - 863 (15 Jun 2006)].

    200701261120

    What is amazing to me is that the author of the C&EN review didn’t comment on how related these two items are. I did not read the Nature article and maybe it does mention the possibility of using this reaction for this specific compound. I’ve not sat down to analyze what would be needed and am not familiar enough with this reaction to know what groups it might tolerate without affecting the overall reaction, but it certainly is a fascinating idea.

    Technorati Tags: ,

    Email Ed Vawter



    Related Posts:
  • Suzuki Reactions of Secondary Alkyl Chlorides Amino Alcohols as Ligands for Nickel-Catalyzed Suzuki Reactions of Unactivated Alkyl Halides, Including Secondary Alkyl Chlorides, with Arylboronic Acids
  • How to avoid fake Tamiflu
  • New Warnings on Tamiflu
  • Amount of Reaction Solvent in Extraction Solvents
  • Amount of Reaction Solvent in Extraction Solvents

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    January 22, 2007

    Amount of Reaction Solvent in Extraction Solvents

    by @ 1:55 pm.  Filed under Science, Chemistry Articles

    One of the omnipresent tasks in organic chemistry is how to work up a reaction. One of my pet peeves is the many articles that say something along the lines of “worked up in the usual manner” or “extracted with toluene” and no further information is given such as the amount or number of times the extraction was performed. It was interesting to me to see an article talking about the extraction process and how the extraction of not only the product, but also the original reaction solvent is often of immense import in downstream processing such as washing or crystallization.

    Removal of Reaction Solvent by Extractive Workup: Survey of Water and Solvent Co-extraction in Various Systems (abstract) Delhaye, L., Ceccato, A., Jacobs, P., Kottgen, C., and Merschaert, A.
    Org. Process Res. Dev., 11, 1, 160 - 164, 2007, 10.1021/op060154k

    This article looks at a variety of reaction solvents; DMSO, DMF, NMP, DMAc, TMU, DMI, THF, 1,4-dioxane, diglyme, and acetonitrile and how they perform with extraction solvents such as toluene, EtOAc, iPrOAC, 1-chlorobtuane and heptane in aqueous solutions such as water and salt water.

    The article is well wroth reading and noting for future use.

    This is in the first issue of the journal for this year and is available to everyone. Typically for some ACS journals the first issue of the year is free and available to everyone.

    Removal of Reaction Solvent by Extractive Workup: Survey of Water and Solvent Co-extraction in Various Systems (pdf) or alternative html

    Here is the Supporting Info.

    Technorati Tags: ,

    Email Ed Vawter



    Related Posts:
  • Amount of Reaction Solvent in Extraction Solvents
  • MeTHF as an Alternative to THF
  • 1H NMR and 13C NMR solvent data in Excel for common laboratory solvents
  • Changing Solvent Can Eliminate or Reduce Impurities
  • MeTHF as Solvent Solvent Applications of 2-Methyltetrahydrofuran in Organometallic and Biphasic Reactions

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Amount of Reaction Solvent in Extraction Solvents

    by @ 12:55 pm.  Filed under Science, Chemistry Articles

    One of the omnipresent tasks in organic chemistry is how to work up a reaction. One of my pet peeves is the many articles that say something along the lines of “worked up in the usual manner” or “extracted with toluene” and no further information is given such as the amount or number of times the extraction was performed. It was interesting to me to see an article talking about the extraction process and how the extraction of not only the product, but also the original reaction solvent is often of immense import in downstream processing such as washing or crystallization.

    Removal of Reaction Solvent by Extractive Workup: Survey of Water and Solvent Co-extraction in Various Systems (abstract) Delhaye, L., Ceccato, A., Jacobs, P., Kottgen, C., and Merschaert, A.
    Org. Process Res. Dev., 11, 1, 160 - 164, 2007, 10.1021/op060154k

    This article looks at a variety of reaction solvents; DMSO, DMF, NMP, DMAc, TMU, DMI, THF, 1,4-dioxane, diglyme, and acetonitrile and how they perform with extraction solvents such as toluene, EtOAc, iPrOAC, 1-chlorobtuane and heptane in aqueous solutions such as water and salt water.

    The article is well wroth reading and noting for future use.

    This is in the first issue of the journal for this year and is available to everyone. Typically for some ACS journals the first issue of the year is free and available to everyone.

    Removal of Reaction Solvent by Extractive Workup: Survey of Water and Solvent Co-extraction in Various Systems (pdf) or alternative html

    Here is the Supporting Info.

    Technorati Tags: ,

    Email Ed Vawter



    Related Posts:
  • Amount of Reaction Solvent in Extraction Solvents
  • 1H NMR and 13C NMR solvent data in Excel for common laboratory solvents
  • MeTHF as an Alternative to THF
  • Telescoping reactions reduces emissions
  • Changing Solvent Can Eliminate or Reduce Impurities

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    MeTHF as Solvent Solvent Applications of 2-Methyltetrahydrofuran in Organometallic and Biphasic Reactions

    by @ 12:34 pm.  Filed under Science, Chemistry Articles

    I’ve written before about MeTHF and though I’d pass along some information I recently came across in the journal Org. Proc Res and Dev.

    Solvent Applications of 2-Methyltetrahydrofuran in Organometallic and Biphasic Reactions (abstract)
    Aycock, D.F. Org. Process Res. Dev., 11, 1, 156 - 159, 2007, 10.1021/op060155c

    Luckily for most, this is in the first issue of the year and is avaiable to everyone. Typically, it is for subscribers only. Free full aticle link Solvent Applications of 2-Methyltetrahydrofuran in Organometallic and Biphasic Reactions (pdf) or an alternate html.

    I should point out though that the article is by David F. Aycock who works for Penn Speciality Chemicals and is a primary supplier of MeTHF.

    There are several factors that make it such an interesting solvent.

    On the downside though, this solvent is significantly more expensive than THF. Penn makes the argument though that you don’t have to use an extraction solvent that you must use with THF or that you can make more concentrated solutions of Grignard and so therefore use less solvent.

    It is a good article and well worth reading and noting for future use for all chemists.

    You can also view other articles in this free issue of Org. Proc Res. & Dev.

    Other Resources

    Products”>Penn Specialty Chemical Inc. > Products MeTHF
    Methyltetrahydrofuran: How to Recover and Dry MeTHF Batchwise (pdf)
    Penn Specialty Chemicals Inc.
    ChemExper - catalog of chemical suppliers, physical characteristics and search engine (methyltetrahydrofuran)

    Technorati Tags: , ,

    Email Ed Vawter



    Related Posts:
  • MeTHF as an Alternative to THF
  • FDA Changes Approval Process for Some Generic Drugs
  • Lesser known solvents
  • Telescoping reactions reduces emissions
  • Simplified Swern oxidation A Simple Modification to Prevent Side Reactions in Swern-Type Oxidations Using Py·SO3

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    January 2, 2007

    Political Interferrence in US Science

    by @ 12:13 pm.  Filed under Science

    I have been preparing my next podcast for Searching the Internet on government sources of information and have been debating how to deal with the politicization of science in recent years. It use to be that politicians used science to help direct public policy and make decisions that affect the country. Now however, it seems the policy is decided and the scientist are being coerced or forced into making their results fit the policy. This means that a released report from a US government science based source is always suspect especially in areas of controversial issues such as sex education and condom use, stem cell research, global warming, and evolution.

    This article from mid-Dec from the BBC News gives some idea of the extent of the problem.

    BBC NEWS | Science/Nature | US scientists reject interference

    The statement they report on was signed by over 10,000 scientist from a wide variety of the sciences and included 52 Noble prize winners. I am hopeful that with the last elections, their will again be some oversight and sanity brought back to the topic of using science to help Americans and the world as a whole.

    I have mentioned Chris Mooney before and his book The Republican War on Science” (Chris Mooney). He also has a great blog The Intersection. I highly recommend both.

    Other Resources
    A to Z Guide to Political Interference in Science

    Dear Kitty. Some blog :: USA: voice of science stifled in Bush administration :: December :: 2006
    Dear Kitty. Some blog :: USA: Bush administration gags scientists :: December :: 2006
    AlterNet: Junking Science (interview with Chris Mooney)
    New Statesman - Right and wrong (review of Republican War on Science)
    Spot-On: Christopher Brauchli: Closed Doors, Closed Minds, Closed Science

    Email Ed Vawter



    Related Posts:
  • Science Searching on the Internet
  • Nova episode “Conquest of Cold”
  • Evolutionary Biology Not An Accepted Major?
  • Washington Times Wants Recess Appointment of von Eschenbach?!
  • Limit Google Search Results to Web Feeds (RSS feeds)

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    December 14, 2006

    Taco Bell E. Coli Probably Lettece Not Green Onions U.S.

    by @ 4:19 pm.  Filed under Science, Health News

    I did want to clarify something I reported on earlier. I had said that the Taco Bell e. coli problem was likely caused by green onions but it now seems that may not have been the case.

    Lettuce May Have Caused Taco Bell E. Coli Outbreak

    Now the likely culprit is lettuce. Cheese has been ruled out because all the cheese use is pasteurized and therefore it is unlikely to be the source of the contamination.

    Being as there is no clear answer, this may lead to lingering problems for Taco Bell.

    Technorati Tags: , ,

    Email Ed Vawter



    Related Posts:
  • Officials track E. coli strain to Calif. Follow Up on Taco Johns
  • E. Coli Outbreaks and Food Safety
  • California OKs Plan Against E. Coli Outbreaks
  • FDA May Approve Irradiation of Produce
  • FDA May Approve Irradiation of Produce

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    December 12, 2006

    High Throughput is Not THE ANSWER to Pharma Productivity

    by @ 2:38 pm.  Filed under Science, Drug Development, Pharma

    I’ve seen many articles come across my desk in the last few months and they all seem to focus on high throughput experimentation being THE ASNWER to the pharmaceutical industry’s productivity problems. The latest was from Chemical Processing on Oct 2006.

    Process Engineering | R&D takes the fast track | Chemical Processing

    Many of these articles focus on automated systems working overnight and lowering labor costs. While I don’t dispute that, I think there needs to be more thought put into what you can learn from this and how it can be used effectively. In some ways, it reminds me of when desktop publishing first came to personal computers and people used dozens of fonts, formatting and colors simply because they were could. After a while, people realized that using these indiscriminately just because you could, did not result in better communication of ideas. The same holds true with automated high throughput experimentation. Just because you can perform thousands of experiments in a week doesn’t mean you should or that you are getting the best answer. Doing 1,000 reactions in two weeks isn’t as productive as 200 carefully chosen and designed experiments done in three days.

    Here are my basic points.

    1. There is a need to work smarter not faster.
    2. Better use needs to be made of the data generated.

    First, I am a firm believer in spending time up front thinking about the problem before starting to do experimentation. This avoids the “Ready, Fire Aim” mentality that seems to be so pervasive in some R&D departments. I understand this tendency and fell into that trap myself early in my career. However, taking the time to think through the possible variables that could have an impact is a worthwhile exercise.

    One of the most important aspects of this thinking ahead before performing experiments involves, design of experiments. This is a way of running reactions to get the greatest amount of information from the smallest number of experiments. While it may not be as imperative as it was in the past to run a small number of experiments, it still is valuable to run the best set of experiments possible. Using advanced software, it is possible to get the best set of experiments regardless of how many variables there may be or whether or not those variables are discrete in nature (such as which catalyst to use) or non-continueous (where only a given set of of conditions can be ran). I would point out that QD Information Services has the capability to design experiments specifically for your situation.

    The second point involves better use of the data generated. I have come across too many situations where the approach was to run hundred or thousands of experiments and then sort those in a spreadsheet and go forward with the top one or two choices. At a major process development conference last year, one of the top ten pharmaceutical process development directors made a point of listing all the reactions they had run to find the “best results”. At the end I stood up and asked what they did with the data and got the reply that basically they had solved the problem and moved on to the next problem.

    The problems with this approach is it does not take advantage of all the experiments that have been performed. Why invest the amount of time into setting up that many experiments and collect that much data and not try to get as much information as possible out of it? Also, how do you know you have found the “best answer”? Too many times, it is settling for what is acceptable instead of what is best. This leads to openings for your competitors to come in, find the true optimum and possibly patenting that and preventing you from using the best possible conditions.

    The best approach is to design the experiments up front but even if that doesn’t occur it is possible to do data mining and possibly find meaning in the data. It continues to amaze me the number of large and mid-sized pharmaceutical companies that don’t take advantage of all the data generated to get the most out of their investment. And too many times, the answer I get is they don’t have time to do more and must move on to the next problem. I often offer to do this data mining for them but they still fail to see any value in this activity. To me, I think this is poor decision making and not getting the most out of your investment and it could come back to haunt you.

    I just want to remind folks that QD Information Services can help in these sorts of situation so if you have a need for this, please feel free to contact me and I’ll help you understand how you can get the most out of your data.

    Technorati Tags: , ,

    Email Ed Vawter



    Related Posts:
  • Schering Plough To Stay Independent
  • Reasons I Got Into The Pharmaceutical Industry
  • Does Revamping Big Pharma Make Them More Efficent?
  • AstraZeneca to purchase Shire? Another Potential Merger
  • Lilly Announces Strategic Changes

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Pages (999999): [1] 2 3 » ... Last »

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    May 2008
    S M T W T F S
    « Jan    
     123
    45678910
    11121314151617
    18192021222324
    25262728293031

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    80 queries. 2.145 seconds